29.03.2014 Views

The Butler Pinkerton Calculator: An Update - BVMarketData

The Butler Pinkerton Calculator: An Update - BVMarketData

The Butler Pinkerton Calculator: An Update - BVMarketData

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>The</strong> <strong>Butler</strong> <strong>Pinkerton</strong> <strong>Calculator</strong>:<br />

<strong>An</strong> <strong>Update</strong><br />

American Society of Appraisers<br />

Advanced BV Conference<br />

October 20, 2009<br />

Peter J. <strong>Butler</strong>, CFA, ASA<br />

1


Learning Objectives:<br />

• Problems with traditional factor models: Use at own<br />

peril!<br />

• <strong>The</strong> Choice: Empirical Data v. No data<br />

– <strong>The</strong> choice is yours:<br />

• Make it wisely<br />

• Impeach inferior cost of capital estimates<br />

• Secondary Choices: Empowerment/Transparency<br />

• Other Applications for the <strong>Calculator</strong><br />

Determination of the proper capitalization rate<br />

presents one of the most difficult problems in<br />

valuation – RR 59-60<br />

2


Let’s Get Some Things Out of the Way First<br />

• You can do all of these calculations yourself.<br />

– You do not need the BPC!<br />

• Total Beta and the BPC violate the CAPM!<br />

– So does every single privately-held company!<br />

– <strong>The</strong> size premium violates the CAPM.<br />

– <strong>The</strong> CSRP violates the CAPM.<br />

– Total Beta and the BPC do not, however, violate financial theory<br />

for individual assets.<br />

• Total Beta assumes a completely undiversified investor (or pool of<br />

completely undiversified investors)<br />

– Good assumption? It depends on the assignment<br />

– Regardless, it is still a data point that is better than guessing<br />

• Not asking you to abandon other cost of capital models, BUT:<br />

3


<strong>The</strong> BUM is Problematic<br />

• Double counting size risk and industry risk?<br />

– Both based on actual returns compared to expected returns<br />

based on beta<br />

• Size risk and CSR risk are next to impossible to separate<br />

– Is a company risky because it is small or is it small because it is<br />

risky?<br />

– Yes and Yes!<br />

• Is there a liquidity premium in the size premium?<br />

– Highly likely<br />

• Is there a liquidity premium in the industry risk premium?<br />

– Likely<br />

• Industry risk premium may include questionable guidelines<br />

• How much different would the data look if another day of the month<br />

had been selected?<br />

• After you get through the gauntlet above; You still have to<br />

completely guess at the CSRP!<br />

4


Traditional Factor Models: Use at Own Peril!<br />

Negative risk factors +/- Numeric Listing<br />

Operating history, volatility of rev & earn. +++ 3.5 X<br />

Lack of management depth ++ 1.0 X<br />

Lack of access to capital resources + 0.5 X<br />

Over reliance on key persons ++ 1.0 X<br />

Lack of size and geographic diversification + 0.5 X<br />

Lack of customer diversification 0.0<br />

Lack of marketing resources + 0.5 X<br />

Lack of purchasing power 0.0<br />

Lack of product/market. dev. resources + 0.5 X<br />

Over reliance on vendors/suppliers 0.0<br />

Limitations on distribution system 0.0<br />

Limitations on fin. reporting/controls + 0.5 X<br />

Positive risk factors<br />

Where is<br />

the<br />

empirical<br />

data?<br />

Long term contracts, unique product 0.0<br />

Patents, copyrights, franchise rights - (1.0) X<br />

Net increase to Cost of Equity 7.0 7.0 7.0<br />

5


<strong>The</strong> Problem: What Do the Courts Want?<br />

• Gesoff v. IIC Industries<br />

– “This court has also explained that we have been<br />

understandably . . . suspicious of expert<br />

valuations offered at trial that incorporate<br />

subjective measures of company-specific risk<br />

premia, as subjective measures may easily be<br />

employed as a means to smuggle improper<br />

risk assumptions into the discount rate so as<br />

to affect dramatically the expert’s ultimate<br />

opinion on value.”<br />

6


<strong>The</strong> Courts Want Empirical Data!<br />

• Delaware Open MRI Radiology Associates<br />

v. Howard B. Kessler, et al<br />

– “To judges, the company specific risk<br />

premium often seems like the device<br />

experts employ to bring their final<br />

results into line with their clients’<br />

objectives, when other valuation<br />

inputs fail to do the trick.”<br />

7


Summary of Factor Models<br />

• Excellent models to understand Size:CSR<br />

• But, do not provide what the courts want:<br />

– Empirical data on Total Risk and/or CSR<br />

• If you want to make enemies, try to change<br />

something.<br />

Woodrow Wilson, 28 th President of the United States<br />

8


<strong>The</strong> Solution: Total Beta and the BPC<br />

Solving for the only unknown in the two equations, CSRP:<br />

• TCOE = R f + Tβ*ERP = R f + β*ERP + SP + CSRP<br />

Professors of<br />

Finance and<br />

Economics<br />

Damodaran<br />

Well–known appraisers<br />

CAPM<br />

Modified CAPM<br />

Risk Allocation:<br />

• Combined Size:CSRP = (Tβ–β)*ERP<br />

• CSRP = (Tβ–β)*ERP – SP<br />

BPC<br />

“Market approach twist to developing a discount rate.”<br />

9


<strong>The</strong> <strong>Calculator</strong> is:<br />

1) Empirical,<br />

2) Transparent,<br />

3) Real-time (or as close as possible),<br />

4) <strong>The</strong> only source (that appraisers typically<br />

rely upon) that captures total risk, and<br />

5) Empowering<br />

12


More Transparency<br />

13


Practical Advice<br />

• This is clearly a great addition to what we<br />

have done in the past. We used to use<br />

Cost of Capital Quarterly to get an idea of<br />

the cost of equity by SIC code. We would<br />

adjust from there. Now, instead of using<br />

the entire industry, we can choose<br />

better guideline data as a starting point.<br />

– Gary Trugman, CPA/ABV, MCBA,<br />

ASA<br />

14


Impeach Inferior Estimates of Cost of Capital<br />

Build-Up Method:SIC Code 8742<br />

(Management Consulting Services, but really interested in litigation<br />

consulting)<br />

• ACCESS WORLDWIDE CMMNCTNS<br />

• ADVISORY BOARD CO<br />

• AON CORP<br />

• BEARINGPOINT INC<br />

• BUTLER NATIONAL CORP<br />

• CIRTRAN CORP<br />

• COMFORCE CORP<br />

• CORPORATE EXECUTIVE BRD CO<br />

• CROSS COUNTRY HEALTHCARE INC<br />

• DIAMOND MANAGEMENT & TECHNL<br />

• ELOYALTY CORP<br />

• EMCOR GROUP INC<br />

• EXPONENT INC<br />

• FTI CONSULTING INC<br />

• GARTNER INC<br />

• HALLWOOD GROUP INC<br />

• HEWITT ASSOCIATES INC<br />

• HURON CONSULTING GROUP INC<br />

• INVENTIV HEALTH INC<br />

• LECG CORP<br />

• MANAGEMENT NETWORK GROUP INC<br />

• MAXIMUS INC<br />

• NAVIGANT CONSULTING INC<br />

• OCEANIC EXPLORATION CO<br />

• PAREXEL INTERNATIONAL CORP<br />

• PDI INC<br />

• PHC INC/MA -CL A<br />

• QUANTUM GROUP INC<br />

• RAHAXI INC<br />

• REHABCARE GROUP INC<br />

• SOUTHWEST CASINO CORP<br />

• SPHERIX INC<br />

• SUNRISE SENIOR LIVING INC<br />

• TALEO CORP<br />

• TETRA TECH INC<br />

• THOMAS GROUP INC<br />

• TRI-ISTHMUS GROUP INC<br />

• TURNAROUND PARTNERS INC<br />

• TYSON FOODS INC -CL A<br />

• UNITEDHEALTH GROUP INC<br />

• VERSAR INC<br />

• WATSON WYATT WORLDWIDE INC<br />

15


<strong>The</strong> “Battle of the Experts” is Over Before it Even Began<br />

Total Cost of Equity (TCOE)<br />

Litigation Consulting Firms<br />

More defensible<br />

18.50%<br />

18.00%<br />

17.50%<br />

Empirical data<br />

BPC<br />

BPC<br />

17.00%<br />

16.50%<br />

16.00%<br />

15.50%<br />

BPC<br />

BPC<br />

BUM<br />

Out of<br />

thin air<br />

15.00%<br />

Guess<br />

14.50%<br />

14.00%<br />

FCN ($2.7B) HURN ($1.0B) NCI ($600M) CRAI ($265M) Subject ($?)<br />

Subject: risk-free=4.16% (5/18/09); ERP = 6.5%; BUM = build-up method: IRP = -1.46%; SP = 5.81%; CSRP = 0.5% (Guess);<br />

BPC = <strong>Butler</strong> <strong>Pinkerton</strong> <strong>Calculator</strong>: 5-year-lookback; Market proxy = S&P 500<br />

16


Interesting Observation: “I Don’t Have<br />

any Good Guidelines!”<br />

• BUM with an IRP: You already have assumed<br />

“good” guidelines – at least for systematic risk.<br />

– Use BPC to impeach inferior estimates of the<br />

cost of capital<br />

• Broaden your search: Guidelines = guidance<br />

– Joyce C. Hall v. Commissioner:<br />

• Hallmark Cards v. MCD, BUD, IBM, KO,<br />

AVP<br />

• Many small publicly-traded companies.<br />

• Company-specific risk is just that – company<br />

specific.<br />

17


Practical Advice Related to Guidelines<br />

• Frankly, it was this analysis (reviewing Forms 10-K, etc.)<br />

that gave me the best insight into the characteristics<br />

that affect risk in this industry. I don’t believe that you<br />

can reasonably assess company specific risk factors<br />

without an understanding and analysis of the<br />

benchmarks derived from the BPC.<br />

• I much prefer BPC because it forces me to examine<br />

public company data about industry risk factors and value<br />

drivers which is available through public filings, press<br />

releases, analyst reports, etc. <strong>The</strong> data is much more<br />

comprehensive in nature than the limited data<br />

available for private companies.<br />

– James M. Skorheim, JD, CPA/ABV/CFF, CFE, CVA,<br />

CrFA<br />

18


Other BPC Applications:<br />

• First, we do a significant amount of Fair Value compliance<br />

work, and the BPC is a great tool for developing capital<br />

costs for hypothetical market participants. We've had<br />

general acceptance of this method in audit review, and it's<br />

a great time saver.<br />

• Second, in documenting a decision regarding discounts for<br />

lack of marketability, we regularly use QMDM as one of the<br />

methods considered. <strong>The</strong> BPC enables us to develop<br />

actual market equity returns for smaller publicly traded<br />

companies, providing a lower limit for the expected return<br />

input in QMDM.<br />

– James B. Lurie, CPA/ABV, ASA, CBA, CVA, BVAL, CIRA<br />

19


Other BPC Applications (continued):<br />

• In using the market approach, the market multiples can be adjusted not<br />

only for size and growth, but also for the CSRP. Again, the judgment gap<br />

is narrowed. Finally, I have found that the variance between the values<br />

determined by the income and GPTC methods has been significantly<br />

reduced.<br />

– Donald P. Wisehart, ASA, CPA/ABV/CFF, CVA, MST<br />

• <strong>The</strong>re is a reason why your method (BPC) and our method (used to adjust<br />

public company multiples for CSR) are similar, that’s because both are<br />

actually the same method, developed a long time ago.<br />

– Vicentiu M. Covrig, Ph.D., CFA in an e-mail to <strong>Butler</strong><br />

<strong>The</strong>re is nothing more difficult to take in hand, more perilous to conduct,<br />

or more uncertain in its success, than to take the lead in the introduction<br />

of a new order of things.<br />

– Niccolo Machiavelli, Italian philosopher<br />

20


Other BPC Applications (continued): 123R<br />

21


Other BPC Applications (continued): In Search of the “True” Beta<br />

Beta Source Market Proxy Period Frequency Adjustment<br />

1 Bloomberg Over 20 domestic series Adjustable Adjustable (0.67*OLS Beta)+(0.33*1.0)<br />

2 Compustat S&P 500 5 years Monthly None<br />

3 Ibbotson S&P 500 5 years Monthly Adjusted toward peer group beta<br />

weighted by stat. significance<br />

4 Value Line NYSE Composite 5 years Weekly 0.35+0.67*OLS Beta<br />

5 Yahoo!Finance S&P 500 3 years Monthly None<br />

6 BPC 6 domestic series Adjustable Weekly - default None<br />

Adjustable - manual<br />

BPC rank 2nd Tied first 2nd Debatable<br />

Sources: Table 6-11, SBBI Valuation Yearbook and definitions from Yahoo!Finance.<br />

22


Total Beta:BPC and Peer Review<br />

1) Referenced in AICPA textbook<br />

written by G. Trugman,<br />

Understanding Business<br />

Valuation;<br />

2) Referenced in PPC’s 19 th<br />

<strong>An</strong>nual Guide to Business<br />

Valuations;<br />

3) Referenced in CCH’s Business<br />

Valuation Guide;<br />

4) E-book in collaboration with<br />

Morningstar;<br />

5) Current <strong>Update</strong> in<br />

Valuations/part of training<br />

material for NACVA;<br />

6) Part of HBS Case Study;<br />

7) Numerous independent<br />

endorsements and<br />

testimonials;<br />

8) Can be proven with the Sharpe<br />

ratio. It is just CAPM theory<br />

for the undiversified investor;<br />

9) Academic support;<br />

10) More than 10 articles;<br />

11) Numerous presentations;<br />

12) Cost of Capital, 3 rd edition<br />

23


Independent Select Testimonial<br />

• Total beta is a widely accepted measure of<br />

risk in situations where investors are not<br />

well diversified. <strong>The</strong> <strong>Butler</strong>-<strong>Pinkerton</strong><br />

<strong>Calculator</strong> is a convenient and flexible<br />

tool for quickly arriving at an objective<br />

estimate of total beta and the company<br />

specific risk premium for a privately held<br />

company.<br />

– Keith Harvey, Ph.D., CFA (A finance professor<br />

made aware of Mr. Kasper’s allegations)<br />

24


<strong>An</strong>other Select Testimonial<br />

• We believe that the <strong>Butler</strong>-<strong>Pinkerton</strong> <strong>Calculator</strong><br />

is a useful tool for appraisers who want a<br />

quantitative way to assess the maximum<br />

CSRP. What the Total Beta and calculator<br />

computes is the maximum or upper bound for<br />

the CSRP. A good appraisal should also use<br />

subjective techniques and judgment to<br />

determine the appropriate CSRP for the<br />

subject company.<br />

– Vicentiu M. Covrig, Ph.D., CFA and Daniel<br />

McConaughy, ASA, Ph.D. (Finance professors made<br />

aware of Mr. Kasper’s allegations)<br />

25


Total Beta and <strong>The</strong> BPC: Why Not Now?<br />

• Subjective Factor Models Provide NO empirical data for<br />

Total Risk or CSRP!<br />

– <strong>An</strong>y other source is subject to harsh criticism<br />

– BPC is not a solution in search of a problem<br />

• BPC provides (moderately subjective) EMPIRICAL data:<br />

– Defend/support all assumptions/inputs<br />

• No different than any other cost of capital input<br />

– Except the BPC provides real-time, transparency for<br />

specific guidelines<br />

– Except the BPC empowers you to observe the<br />

sensitivities in the calculations<br />

26


Questions to Consider:<br />

• If Total Beta and the BPC (which empirically<br />

capture total risk) were developed first, would<br />

you abandon them to rely upon other databases<br />

(which only capture partial risk)?<br />

• If Total Beta and the BPC were developed first,<br />

would you abandon them to rely upon the purely<br />

subjective factor models (which require a<br />

complete guess for a CSRP)?<br />

– One thing we do recognize is that the valuation profession can use<br />

more tools grounded in market observations to help develop discount<br />

rates – Roger Grabowski; BV <strong>Update</strong> - November 2006<br />

• Note: <strong>The</strong> BPC was commercialized in November 2007<br />

27


Questions<br />

<strong>An</strong> important scientific innovation rarely makes its way rapidly winning over<br />

and converting its opponents; it rarely happens that Saul becomes Paul.<br />

What does happen is that its opponents gradually die out and the growing<br />

generation is familiarized with the idea from the beginning.<br />

– Max Planck, German physicist, founder of quantum theory<br />

28


<strong>The</strong> <strong>Butler</strong> <strong>Pinkerton</strong> <strong>Calculator</strong>:<br />

<strong>An</strong> <strong>Update</strong> and A Response<br />

American Society of Appraisers<br />

Advanced ASA BV Conference<br />

October 20, 2009<br />

Peter J. <strong>Butler</strong>, CFA, ASA<br />

Never let the search for the perfect get in the way of the perfectly good<br />

- John Elson, Time editor<br />

29


Whose Misunderstanding of Financial <strong>The</strong>ory<br />

is the Question<br />

• “We have argued that in equilibrium there will be a simple<br />

linear relationship between the expected return and standard<br />

deviation of return for efficient combinations of risky assets.<br />

Thus far nothing has been said about such a relationship for<br />

individual assets. Typically the ER, σR values associated with<br />

single assets will lie above the capital market line, reflecting the<br />

inefficiency of undiversified holdings. Moreover, such points may be<br />

scattered throughout the feasible region, with no consistent<br />

relationship between their expected return and total risk (σR).<br />

However, there will be a consistent relationship between their<br />

expected returns and what might best be called systematic risk, as<br />

we will now show.”<br />

Portfolio risk<br />

William F. Sharpe (1964), “Capital asset prices: A theory of market<br />

equilibrium under conditions of risk,” Journal of Finance, 19 (3), p.436.<br />

A<br />

Portfolio<br />

30


Are You on the Left-side or the “Right”-side?<br />

• Correlated relative volatility v. Relative volatility<br />

• Covariance v. Standard deviation<br />

• Well-diversified portfolio v. Stand-alone asset<br />

• Portfolio managers v. Appraisers<br />

• Partial risk v. Total risk<br />

• NO empirical data v. Empirical data<br />

• A few appraisers v. Ph.Ds and a growing<br />

number of appraisers<br />

• It’s your choice – I have made mine.<br />

31


Conclusion from Mr. Kasper’s Paper<br />

• “Until the authors provide empirical evidence<br />

that total beta produces better estimates of<br />

actual public company returns…”<br />

– Why would we?<br />

– Mentioned in very first article that the<br />

technique does not do this – Mr. Kasper<br />

missed it!<br />

– CSR is at least partially diversified away for<br />

publicly-held stocks.<br />

• CSR, however, is priced for PRIVATE<br />

companies<br />

• Use Total Beta as a proxy for PRIVATE<br />

companies<br />

32


Other Observations: Instability of Beta<br />

Dnacq Healthcare (DYII)<br />

Dryships (DRYS)<br />

Beta Total Beta Beta Total Beta<br />

Jan-08<br />

Nov-08<br />

Monday 0.34 10.72 Monday 2.88 4.33<br />

Tuesday 1.18 11.60 Tuesday 2.52 4.70<br />

Wednesday 0.60 12.05 Wednesday 2.41 4.39<br />

Thursday 0.60 12.93 Thursday 2.31 4.25<br />

Friday -0.47 11.92 Friday 2.18 3.93<br />

Mean 0.45 11.84 Mean 2.46 4.32<br />

Median 0.60 11.92 Median 2.41 4.33<br />

SD 0.60 0.80 SD 0.27 0.28<br />

CV 1.33 0.07 CV 0.11 0.06<br />

33


Other Findings (continued):<br />

• Statistical errors with beta (instability of beta) (continued)…<br />

– Total beta (TCOE-side of <strong>Calculator</strong>) is relatively immune<br />

– BPC uses OLS beta to keep the following intact:<br />

• Other commercial sources use OLS regression<br />

– Recommendations: Calculations are very quick and easy<br />

• Look at all 5 days of the trading week<br />

• Look at different look-back periods<br />

• T-stat greater than 80% (or whatever you so choose)<br />

• Select an appropriate R-square as a hurdle<br />

• Question: Maybe a low R-square captures exactly what it should<br />

be capturing – a stock with low systematic risk?<br />

34


Response to Roger Grabowski’s Slides<br />

• Which is it?<br />

– “<strong>The</strong> cost of capital should reflect the risk of<br />

the investment, not the cost of funds to the<br />

investor”.<br />

– “Risk of an investment and its FMV must be<br />

developed based on the risks (and pricing)<br />

perceived by investors that comprise the pool<br />

of likely buyers for the subject asset…”<br />

• “No one (researchers) uses TCOE = R f +<br />

TB*RP m ”<br />

– Why would an academic use TCOE?<br />

– TCOE is not priced in the public markets<br />

35


Response to Roger Grabowski’s Slides<br />

• “CSRP estimates derived from beta estimates are subject to<br />

estimation error (i.e., CSRP estimates are unreliable)”<br />

– True; Use all five days of the trading week<br />

– Duff & Phelps’ data, dependent upon sum beta, is also subject to<br />

estimation error<br />

• How would Duff & Phelps or Morningstar’s data look if<br />

another day of the month was used?<br />

– No one knows. <strong>The</strong> databases are not transparent.<br />

– What is not subject to estimation error? This is valuation!<br />

• “<strong>The</strong> Sharpe Ratio does not cover cases in which one investment<br />

return is involved”<br />

– Other than in private company valuation there are no individual<br />

investments.<br />

– Stocks are part of portfolios<br />

36


Summary:<br />

• All models are wrong, but some are useful.<br />

George Box, statistician<br />

– Total beta and the BPC are very useful.<br />

– You can use them (or perform the calculations yourself)<br />

and be subject to Mr. Kasper’s alleged criticisms or be<br />

subject to harsh criticisms from the Court.<br />

• Your Choice!<br />

• It takes a model to beat a model.<br />

Milton Friedman, Nobel Prize winning economist<br />

– Total beta and/or the BPC have beaten other<br />

models/databases that require a complete guess for<br />

CSRP:<br />

1) <strong>An</strong>d do not empirically capture total risk and<br />

2) Are not transparent and empowering<br />

37

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!